Junshi Biosciences and Coherus Announce Positive Final Overall Survival Results of JUPITER-02, a Phase 3 Clinical Trial Evaluating Toripalimab as Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma
Globe Newswire15-02-2023, 21:25
eXp Realty Unveils Game-Changing ICON and Revenue Share Capping Incentive Programs at eXpcon Miami 29-10-2024, 20:45